Center for Drug Evaluation and Research |
1260.1 |
Office of the Center Director |
1261.1 |
Office of Regulatory Policy |
1260.2 |
Division of Regulatory Policy I |
1260.21 |
Division of Regulatory Policy II |
1260.22 |
Division of Information Disclosure Policy |
1260.23 |
Division of Regulatory Policy III |
1260.24 |
Division of Regulatory Policy IV |
1260.25 |
Office of Management |
1261.10 |
Division of Budget Execution and Resource Management |
1261.11 |
Division of Management Services |
1261.17 |
Division of User Fee Management and Budget Formulation |
1261.18 |
Office of Communications |
1261.20 |
Division of Digital and Online Communications |
1261.22 |
Division of Health Communication |
1261.25 |
Division of Drug Information |
1261.26 |
Office of Surveillance and Epidemiology |
1261.5 |
Office of Medication Error Prevention and Risk Management |
1261.57 |
Division of Medication Error Prevention and Analysis I |
1261.571 |
Division of Risk Management |
1261.572 |
Division of Medication Error Prevention and Analysis II |
1261.573 |
Division of Mitigation Assessment and Medication Error Surveillance |
1261.574 |
Office of Pharmacovigilance and Epidemiology |
1261.58 |
Division of Epidemiology I |
1261.581 |
Division of Epidemiology II |
1261.582 |
Division of Pharmacovigilance I |
1261.583 |
Division of Pharmacovigilance II |
1261.584 |
Office of Compliance |
1262.1 |
Office of Unapproved Drugs and Labeling Compliance |
1262.3 |
Division of Compounded Drugs |
1262.31 |
Division of Unapproved New Drugs |
1262.32 |
Office of Manufacturing Quality |
1262.4 |
Division of Drug Quality I |
1262.45 |
Division of Drug Quality II |
1262.46 |
Division of Drug Quality III |
1262.47 |
Office of Scientific Investigations |
1262.5 |
Division of Good Clinical Practice Compliance |
1262.52 |
Division of Safety Compliance |
1262.53 |
Division of Enforcement and Postmarket Safety |
1262.54 |
Division of Clinical Compliance Evaluation |
1262.55 |
Office of Drug Security, Integrity and Response |
1262.6 |
Division of Global Drug Distribution and Policy |
1262.61 |
Division of Supply Chain Integrity |
1262.62 |
Office of Program and Regulatory Operations |
1262.7 |
Office of Compounding Quality and Compliance |
1262.8 |
Division of Compounding I |
1262.81 |
Division of Compounding II |
1262.82 |
Division of Compounding Policy and Outreach |
1262.83 |
Office of New Drugs |
1263.1 |
Office of Administrative Operations |
1263.11a |
Office of Nonprescription Drugs |
1263.12a |
Division of Nonprescription Drugs I |
1263.121 |
Division of Nonprescription Drugs II |
1263.122 |
Office of Specialty Medicine |
1263.13a |
Division of Ophthalmology |
1263.131 |
Division of Imaging & Radiation Medicine |
1263.132 |
Office of New Drug Policy |
1263.14a |
Division of Clinical Policy |
1263.141 |
Division of Regulatory Policy |
1263.142 |
Office of Regulatory Operations |
1263.15a |
Division of Regulatory Operations for Infectious Disease |
1263.151 |
Division of Regulatory Operations for Oncologic Disease |
1263.152 |
Division of Regulatory Operations for Nonprescription Drugs |
1263.153 |
Division of Regulatory Operations for Neuroscience |
1263.154 |
Division of Regulatory Operations for Cardiology, Hematology, Endocrinology & Nephrology |
1263.155 |
Division of Regulatory Operations for Immunology & Inflammation |
1263.156 |
Division of Regulatory Operations for Rare Diseases, Pediatrics, Urology & Reproductive Medicine |
1263.157 |
Division of Regulatory Operations for Specialty Medicine |
1263.158 |
Office of Program Operations |
1263.16a |
Office of Drug Evaluation Science |
1263.17a |
Division of Clinical Outcome Assessment |
1263.171 |
Division of Biomedical Informatics, Research & Biomarker Development |
1263.172 |
Office of Neuroscience |
1263.20 |
Division of Neurology I |
1263.21a |
Division of Neurology II |
1263.24a |
Division of Psychiatry |
1263.25 |
Division of Anesthesiology, Addiction Medicine & Pain Medicine |
1263.26 |
Division of Pharmacology Toxicology for Neuroscience |
1263.27 |
Office of Cardiology, Hematology, Endocrinology & Nephrology |
1263.30 |
Division of Diabetes, Lipid Disorders & Obesity |
1263.31 |
Division of General Endocrinology |
1263.32 |
Division of Cardiology & Nephrology |
1263.35 |
Division of Non-Malignant Hematology |
1263.36 |
Division of Pharmacology Toxicology for Cardiology, Hematology, Endocrinology & Nephrology |
1263.37 |
Office of Immunology & Inflammation |
1263.40 |
Division of Gastroenterology |
1263.42 |
Division of Dermatology & Dentistry |
1263.45 |
Division of Rheumatology & Transplant Medicine |
1263.46 |
Division of Pulmonology, Allergy & Critical Care |
1263.47 |
Division of Hepatology & Nutrition |
1263.48 |
Division of Pharmacology Toxicology for Immunology & Inflammation |
1263.49 |
Office of Infectious Diseases |
1263.50 |
Division of Anti-Infectives |
1263.51 |
Division of Antivirals |
1263.52 |
Division of Pharmacology Toxicology for Infectious Diseases |
1263.53a |
Office of Rare Diseases, Pediatrics, Urology & Reproductive Medicine |
1263.60 |
Division of Pharmacology Toxicology for Rare Diseases, Pediatrics, Urology & Reproductive Medicine |
1263.61a |
Division of Rare Diseases & Medical Genetics |
1263.62a |
Division of Urology, Obstetrics, & Gynecology |
1263.63a |
Division of Pediatric & Maternal Health |
1263.67 |
Office of Oncologic Diseases |
1263.70 |
Division of Oncology I |
1263.74 |
Division of Hematologic Malignancies I |
1263.75 |
Division of Oncology II |
1263.76 |
Division of Hematology Oncology Toxicology |
1263.77 |
Division of Oncology III |
1263.79 |
Division of Hematologic Malignancies II |
1263.80 |
Office of Therapeutic Biologics and Biosimilars |
1263.90 |
Office of Medical Policy |
1266.1 |
Office of Prescription Drug Promotion |
1266.11 |
Division of Advertising and Promotion Review II |
1266.111 |
Division of Advertising and Promotion Review I |
1266.112 |
Office of Medical Policy Initiatives |
1266.12 |
Division of Medical Policy Development |
1266.121 |
Division of Medical Policy Programs |
1266.122 |
Division of Clinical Trial Quality |
1266.123 |
Office of Executive Programs |
1267.1 |
Division of Learning and Organizational Development |
1267.11 |
Division of Advisory Committee and Consultant Management |
1267.13 |
Office of Translational Sciences |
1268.1 |
Office of Biostatistics |
1268.3 |
Division of Biometrics I |
1268.31 |
Division of Biometrics II |
1268.32 |
Division of Biometrics III |
1268.33 |
Division of Biometrics IV |
1268.34 |
Division of Biometrics V |
1268.35 |
Division of Biometrics VI |
1268.36 |
Division of Biometrics VII |
1268.37 |
Division of Biometrics VIII |
1268.38 |
Division of Biometrics IX |
1268.39 |
Office of Clinical Pharmacology |
1268.4 |
Division of Neuropsychiatric Pharmacology |
1268.41 |
Division of Inflammation & Immune Pharmacology |
1268.42 |
Division of Cardiometabolic & Endocrine Pharmacology |
1268.43 |
Division of Infectious Disease Pharmacology |
1268.44 |
Division of Cancer Pharmacology I |
1268.45 |
Division of Pharmacometrics |
1268.46 |
Division of Applied Regulatory Science |
1268.47 |
Division of Cancer Pharmacology II |
1268.48 |
Division of Translational & Precision Medicine |
1268.49 |
Office of Computational Science |
1268.5 |
Division of Regulatory Review & Research |
1268.51 |
Division of Tools, Technology & Innovation |
1268.52 |
Office of Study Integrity and Surveillance |
1268.6a |
Division of New Drug Study Integrity |
1268.61 |
Division of Generic Drug Study Integrity |
1268.62 |
Office of Administrative Operations |
1268.7 |
Office of Strategic Programs |
1270.2 |
Office of Program and Strategic Analysis |
1270.21 |
Office of Business Informatics |
1270.22 |
Division of Drug Quality and Compliance Services Solution |
1270.222 |
Division of Data Management Services and Solutions |
1270.223 |
Division of Business Management Services and Solutions |
1270.224 |
Division of Regulatory Review and Drug Safety Services Solutions |
1270.225 |
Office of Pharmaceutical Quality |
1280.1a |
Office of Administrative Operations |
1280.11 |
Office of Biotechnology Products |
1280.20 |
Division of Biotechnology Review and Research I |
1280.21 |
Division of Biotechnology Review and Research II |
1280.22 |
Division of Biotechnology Review and Research III |
1280.23 |
Division of Biotechnology Review and Research IV |
1280.24 |
Office of New Drug Products |
1280.30 |
Division of Life Cycle API |
1280.31 |
Division of New Drug API |
1280.32 |
Division of New Drug Products I |
1280.33 |
Division of New Drug Products II |
1280.34 |
Division of Biopharmaceutics |
1280.35 |
Division of New Drug Products III |
1280.36 |
Office of Policy for Pharmaceutical Quality |
1280.40 |
Division of Regulations, Guidance and Standards |
1280.41 |
Division of Internal Policies and Programs |
1280.42 |
Office of Pharmaceutical Manufacturing Assessment |
1280.50 |
Division of Pharmaceutical Manufacturing I |
1280.51 |
Division of Pharmaceutical Manufacturing II |
1280.52 |
Division of Pharmaceutical Manufacturing III |
1280.53 |
Division of Pharmaceutical Manufacturing IV |
1280.54a |
Division of Microbiology Assessment I |
1280.55a |
Division of Microbiology Assessment II |
1280.56 |
Division of Biotechnology Manufacturing |
1280.57 |
Office of Quality Surveillance |
1280.60 |
Division of Quality Data Science |
1280.61 |
Division of Quality Intelligence I |
1280.62 |
Division of Quality Intelligence II |
1280.63 |
Office of Testing and Research |
1280.70 |
Division of Product Quality Research |
1280.71 |
Division of Pharmaceutical Analysis |
1280.72 |
Division of Complex Drug Analysis |
1280.73 |
Office of Program and Regulatory Operations |
1280.80 |
Division of Regulatory and Business Process Management I |
1280.81 |
Division of Regulatory and Business Process Management II |
1280.82 |
Division of Regulatory & Business Process Management III |
1280.83a |
Division of Operational Excellence, Learning & Professional Development |
1280.84 |
Office of Lifecycle Drug Products |
1280.90 |
Division of Immediate & Modified Release Products I |
1280.91 |
Division of Immediate Release Products II |
1280.92 |
Division of Immediate & Modified Release Products III |
1280.93 |
Division of Liquid-Based Products I |
1280.94 |
Division of Liquid-Based Products II |
1280.95a |
Division of Post-Marketing Activities I |
1280.96a |
Division of Post-Marketing Activities II |
1280.97 |
Office of Generic Drugs |
1290.1a |
Office of Research and Standards |
1291.1a |
Division of Therapeutic Performance |
1291.11 |
Division of Quantitative Methods and Modeling |
1291.12 |
Office of Bioequivalence |
1292.1a |
Division of Bioequivalence I |
1292.11 |
Division of Bioequivalence II |
1292.12 |
Division of Bioequivalence III |
1292.13 |
Division of Clinical Review |
1292.14 |
Office of Generic Drug Policy |
1293.1a |
Division of Legal and Regulatory Support |
1293.11 |
Division of Policy Development |
1293.12 |
Office of Regulatory Operations |
1294.1a |
Division of Labeling Review |
1294.11 |
Division of Filing Review |
1294.12 |
Division of Project Management |
1294.13 |
Division of Quality Management Systems |
1294.14 |